Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies

The urgent need for a treatment of COVID-19 has left researchers with limited choice of either developing an effective vaccine or identifying approved/investigational drugs developed for other medical conditions for potential repurposing, thus bypassing long clinical trials. In this work, we compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawat, Puneet, Sharma, Divya, Srivastava, Ambuj, Janakiraman, Vani, Gromiha, M. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119408/
https://www.ncbi.nlm.nih.gov/pubmed/33986382
http://dx.doi.org/10.1038/s41598-021-89621-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119408/
https://www.ncbi.nlm.nih.gov/pubmed/33986382
http://dx.doi.org/10.1038/s41598-021-89621-6

Ejemplares similares